Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma
- 28 May 2015
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 38 (S1) , E970-E980
Abstract
Background: The purpose of this phase II trial was to evaluate the tolerability, safety, and efficacy of a non–5‐fluorouracil (5‐FU)‐based induction chemotherapy followed by chemoradiotherapy (CRT) for patients with locally advanced head and neck squamous cell carcinoma (HNSCC).Methods: Sixty patients with stage III to IV HNSCC were treated with induction paclitaxel and cisplatin (TP; paclitaxel 175 mg/m2 and cisplatin 80 mg/m2, 3 cycles) followed by CRT (cisplatin 100 mg/m2; D1, 22, and 43 of radiotherapy).Results: Fifty‐six patients (93.3%) completed 3 cycles of induction TP (no treatment‐related deaths), 52 (86.7%) completed definitive CRT per protocol (adverse event [AE] grade ≥2 in 53.3%). The overall response rate after induction TP was 82.5% for patients with resectable disease and 55.5% for unresectable disease (p = .023), and complete response (CR) rate after CRT was 70.0% for patients with resectable disease and 30.0% for unresectable disease (p = .005).Conclusion: Induction TP followed by cisplatin based‐CRT was well‐tolerated, safe, and had high overall response rate in selected patients with locally advanced HNSCC. © 2015 Wiley Periodicals, Inc. Head Neck 38: E970–E980, 2016Keywords
Funding Information
- Barretos Cancer Hospital
This publication has 57 references indexed in Scilit:
- Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysisWorld Journal of Surgical Oncology, 2013
- Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neckBMC Cancer, 2013
- Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase I-II StudyOncology, 2013
- Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neckExperimental and Therapeutic Medicine, 2013
- Larynx preservationCurrent Opinion in Oncology, 2012
- Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck regionRadiation Oncology, 2011
- Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapyRadiation Oncology, 2011
- Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancerBiomedical Imaging and Intervention Journal, 2010
- Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective TrialJournal of Clinical Oncology, 2010
- Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized studyAnnals of Oncology, 2009